tomeko

SSR4-congenital disorder of glycosylation

Just diagnosed with SSR4-congenital disorder of glycosylation?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees SSR4-congenital disorder of glycosylation, look for clinical trials, and connect with others living with it — all in one place.

Open the full SSR4-congenital disorder of glycosylation hub →

Overview

SSR4-congenital disorder of glycosylation is a rare condition. Also known as CDG syndrome type Iy, CDG-Iy, CDG1Y, Carbohydrate deficient glycoprotein syndrome type Iy, Congenital disorder of glycosylation type 1y, Congenital disorder of glycosylation type Iy. Tomeko brings together the specialists, research, clinical trials, treatments and community for SSR4-congenital disorder of glycosylation so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:370927 · OMIM 300934 · ICD-10 E77.8 · GARD 0012405

Find care for SSR4-congenital disorder of glycosylation

Authoritative references for SSR4-congenital disorder of glycosylation

Common questions

I was just diagnosed with SSR4-congenital disorder of glycosylation — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees SSR4-congenital disorder of glycosylation, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for SSR4-congenital disorder of glycosylation?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat SSR4-congenital disorder of glycosylation, filtered to your area.

Are there clinical trials for SSR4-congenital disorder of glycosylation?

Tomeko shows live, recruiting studies for SSR4-congenital disorder of glycosylation from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com